We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sagentia Grp | LSE:SGA | London | Ordinary Share | CH0012324965 | CHF0.10 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.00 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 4.00 | GBX |
Sagentia Grp (SGA) Share Charts1 Year Sagentia Grp Chart |
|
1 Month Sagentia Grp Chart |
Intraday Sagentia Grp Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 16/7/2008 | 10:01 | SAGENTIA GROUP AG:::::was Generics Group AG | 294 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 16/5/2008 08:28 by jonwig PICNIC - it would be nice to see more Sensopad royalties arriving: they always seem to get deferred.Meanwhile the SGA share price recovery continues, so I'm comfortably in profit, despite buying my first lot at over 8p. |
Posted at 08/5/2008 15:52 by spital23 Sagentia - SPECULATIVE BUYCompanies: SGA 07/05/2008 Currently poised to emigrate from the Full List to AIM, technology consultancy Sagentia looks unfairly unappreciated by the market. At less than £10m, its market value represents only two thirds of its £14.6m of property assets and, if you include its £7.6m investment portfolio, loans and cash, Sagentia's shares trade at a significant discount to its shareholder funds of 8.1p per share. Understandably there has been a bout of director buying in the past couple of months and new chief executive Dr Alistair Brown, stepping up from sales director, intends to sell off the company's venture portfolio and move to AIM. He says the new focus is 'on earnings rather than equity'. The previous strategy had been to generate shareholder returns by creating spin-out companies, some of which still sit in the portfolio, such as AIM-listed CMR Fuel Cells. Once the venture capital subsidiary is sold off Sagentia will be left with a consultancy arm that last year generated a £500,000 profit from £17.9m of fee income. Operations in the UK, the US, Germany, Hong Kong and Sweden engage in business consultancy and product development. Standout projects include a suite of digital products that have helped transform the prospects of toymaker Hornby, the launch of a mobile payment solution for Vodafone and a delivery system for AstraZeneca that generates Sagentia £500,000 of royalties a year. A move to AIM by the end of June and the appointment of new broker Arbuthnot might help to garner some more attention from small-cap followers. The move might also see 48% shareholder Catella, a sister company of Ikea, reduce its stake. Speculative buy. |
Posted at 08/5/2008 07:59 by jonwig Cyprus ... could be positive or negative, I wouldn't like to hazard which!However, SGA's role in life is to help other companies innovate and flourish. Looking at our share price history doesn't suggest much success on our own part. (Though the corner may have turned now.) As an example of the exalted company we keep: |
Posted at 07/5/2008 21:15 by dorset64 Steve, Yes it is.This months trades to date: Trade Date Trade Time Price Volume Type Consideration Conditions 07/05/2008 16:12:50 4.75 16,842 O 800.00 07/05/2008 14:23:57 4.48 179,348 O 8,041.96 07/05/2008 13:16:09 4.45 20,000 O 890.00 07/05/2008 10:22:00 4.45 100,000 O 4,450.00 06/05/2008 13:06:33 4.25 50,000 O 2,125.00 06/05/2008 08:09:24 4.47 17,901 O 800.00 02/05/2008 16:28:08 4.44 12,168 O 540.02 02/05/2008 16:17:24 4.38 100,000 O 4,375.00 02/05/2008 16:14:19 4.20 20,000 O 840.00 02/05/2008 15:17:26 4.00 44,695 O 1,787.80 02/05/2008 14:59:50 4.20 10,000 O 420.00 02/05/2008 14:57:33 4.25 20,000 O 850.00 02/05/2008 08:56:37 4.12 25,000 O 1,031.25 02/05/2008 08:00:16 3.75 89,500 O 3,356.25 Symbol SGA as in here Dorset |
Posted at 07/5/2008 19:27 by jonwig Ken ... they've just announced (02/05) that Harston Mill is fully let now - hitherto it was almost full.It's valued at £14.1m in the accounts to 31/12/07, and the annual rent was £1.7m (SGA plc gets rent from its operating subsidiary). That tells me a rental yield of 12% - a modern, well-fitted complex with ample parking and security a few miles from Cambridge. You'd think a yield of 6 - 7% maybe? Yet they said it wasn't materially mispriced (last valued 2006). I've asked the company why it's carried at such a low value. PS. I've asked some more questions, which I'll post about when I get a response. |
Posted at 07/5/2008 13:53 by jonwig Sagentia - SPECULATIVE BUYCompanies: SGA 07/05/2008 Currently poised to emigrate from the Full List to AIM, technology consultancy Sagentia looks unfairly unappreciated by the market. At less than £10m, its market value represents only two thirds of its £14.6m of property assets and, if you include its £7.6m investment portfolio, loans and cash, Sagentia's shares trade at a significant discount to its shareholder funds of 8.1p per share. Understandably there has been a bout of director buying in the past couple of months and new chief executive Dr Alistair Brown, stepping up from sales director, intends to sell off the company's venture portfolio and move to AIM. He says the new focus is 'on earnings rather than equity'. The previous strategy had been to generate shareholder returns by creating spin-out companies, some of which still sit in the portfolio, such as AIM-listed CMR Fuel Cells. The venture capital subsidiary was sold off last year for £1.5m, leaving a consultancy arm that generated a £500,000 profit from £17.9m of fee income in 2007. Operations in the UK, the US, Germany, Hong Kong and Sweden engage in business consultancy and product development. Standout projects include a suite of digital products that have helped transform the prospects of toymaker Hornby, the launch of a mobile payment solution for Vodafone and a delivery system for AstraZeneca that generates Sagentia £500,000 of royalties a year. A move to AIM by the end of June and the appointment of new broker Arbuthnot might help to garner some more attention from small-cap followers. The move might also see 48% shareholder Catella, a sister company of Ikea, reduce its stake. Speculative buy. |
Posted at 08/2/2008 13:27 by elgordo I was wondering if/when SGA's share price would be adjusted to reflect the loss in value of the holding in TTX since its float. The numbers are:TTX shares held: 3,177,486 Price fall: 17.5p (float price 40p, current mid-price 22.5p) Loss in value: £556,000 SGA shares in issue: 216m Loss in value per share: 0.26p So, of course, SGA doesn't move for a few days, then drops 0.5p. Sigh. Apart from the loss in value (which, of course, might be regained in due course if TTX recovers), the immediate and precipitous decline in TTX's price after floating will not endear SGA to others as and when it wants to sell or float off other assets. Hopefully they will be able to make a case that it was all down to market conditions at the time, but this story needs a recovery in TTX's price at some point to give it credibility. In the meantime, I'll try and get excited about today's news that Sagentia has been awarded certification to ISO 13485:2003 (see for all the gripping details). |
Posted at 04/1/2008 19:15 by jonwig According to Digital Look, the MCap of TurfTrax at float will be £17.59mand the issue price 40p. That suggests 44m shares in issue, of which SGA will hold 3.2m (7.3%) valued at £1.3m, or 0.6p per SGA share. Each 1p rise in TT's share price will add 0.015p to SGA's NAV. (Will edit these figures when the final details are announced.) |
Posted at 12/10/2007 14:02 by picnic Have just checked the SGA price on the LSE website and found a block trade of 3316153 @2.5p dated 3/10/07. Bradshaws holding ?? Anyway this looks like the stock overhang.If it ever gets cleared (500k traded today)you never know the share price might go up! |
Posted at 07/5/2007 16:52 by jonwig If the SGA share price is to reach 20p solely on the basis of Sphere Medical valuation we have:Currently: 11% of Sph valued at £1.5m, SGA share price = 6.9p, SGA MCap = £14.9m. So SGA priced at 20p, ie. MCap = £43m gives uplift = £28m, so whole of Sph valued at £270m. Is that what you're expecting, adejuk? Whilst I believe SGA to be quite undervalued at these levels, I'm not optimistic enough to embrace your valuation of Sph just yet! BTW, you talk of "Sphere float" and of "Bill & Trade sale". Which is it to be? In a buoyant market, an IPO would be preferable, but who knows, by September? |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
